Australian team pioneers research on curcumin and dementia prevention

An Australian clinical trial into the potential prevention or delay in onset of Alzheimer's disease using a curcumin formula is set to begin its intervention phase. The second part of the trial — KARVIAH (Kerr Anglican Retirement Village Initiative in Ageing Health) — will measure the effects of curcumin, found in the Indian spice turmeric, on 100 residents aged 65 to 90 who live independently in the village.

To continue reading this article, please Log In or Sign Up for access.